Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease
Michael Binks(The Royal Free Hospital), Alan Tyndall(University of Basel), A Gratwohl(University of St.Gallen), Falk Hiepe(Leibniz Association), Paul Emery(University of Leeds), Alicia Martín Martínez(Hospital Universitario Insular de Gran Canaria), Franco Locatelli(Bambino Gesù Children's Hospital), P. A. Bacon(University of Basel), Alberto Martini(The University of Texas MD Anderson Cancer Center), Jürgen Finke(University Medical Center Freiburg), JM van Laar(University of Basel), Ildefonso Espigado(Instituto de Biomedicina de Sevilla), Ina Kötter(Eppendorf (Germany)), Éliane Gluckman(Assistance Publique – Hôpitaux de Paris), F.H.J. van den Hoogen, Leo van de Putte(University of Basel), A. Kashyap(German National Bone Marrow Donor Registry), D E Furst(University of Basel), M J Espinosa Pascual, C. Besenthal(University of Basel), Peter A. McSweeney(Mesoblast (United States)), R. Arnold(University of Basel), A Schattenberg(Radboud University Nijmegen), WE Fibbe(University of Basel), Keith Sullivan(Duke Medical Center), F C Breedveld(University of Basel), B. Hertenstein(University of Basel), HH Peter(University of Basel), H. G. Prentice(University of Basel), A Marmont(National Cancer Research Institute), Dominique Farge(Hôpital Saint-Louis), C Black(The Royal Free Hospital), Jakob Passweg(University Hospital of Basel)
Cited by 287
Related Papers
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
|New England Journal of Medicine|2017|6k
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
|Annals of the Rheumatic Diseases|2020|2.8k
Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial
|The Lancet Oncology|2018|2.3k
KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma
|New England Journal of Medicine|2020|1.9k